English
Home > Products > 7-(2-phenylacetamido)-5-thia-1

China 7-(2-phenylacetamido)-5-thia-1 Factory

We believe in: Innovation is our soul and spirit. Quality is our life. Customer need is our God for 7-(2-phenylacetamido)-5-thia-1,CAS NO 51762-51-7,51762-51-7,Ceftibuten intermediate,Ceftibuten advance intermediate, Should additional details be required, please call us anytime!
7-(2-phenylacetamido)-5-thia-1, We're sticking to excellent quality, competitive price and punctual delivery and better service, and sincerely hope to establish long-term good relationships and cooperation with our new and old business partners from all over the world. Sincerely welcome you to join us.

Related Products

Hot Products

  • METHYL 2-BROMO-4-FLUOROBENZOATE

    METHYL 2-BROMO-4-FLUOROBENZOATE

    Product Name:METHYL 2-BROMO-4-FLUOROBENZOATE
    Molecular Formula:C8H6BrFO2
    Molecular Weight:233.03
    CAS Registry Number:653-92-9
  • Ethyl2-chloropyrimidine-5-carboxylate

    Ethyl2-chloropyrimidine-5-carboxylate

    Product Name:Ethyl2-chloropyrimidine-5-carboxylate
    Molecular Formula:C7H7ClN2O2
    Molecular Weight:186.6
    CAS Registry Number:89793-12-4
  • Amiodarone hydrochloride

    Amiodarone hydrochloride

    Product Name:Amiodarone hydrochloride
    Molecular Formula:C25H29I2NO3.ClH
    Molecular Weight;681.77
    CAS Registry Number;19774-82-4
  • Acetone Semicarbazone

    Acetone Semicarbazone

    Product Name:Acetone Semicarbazone
    Molecular Formula:C4H9N3O
    Molecular Weight;115.13
    CAS Registry Number;110-20-3
  • Methyl 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylate

    Methyl 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylate

    Product Name:Methyl 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylate
    Molecular Formula:C12H11NO4
    Molecular Weight:233.22
    CAS Registry Number:205448-65-3
  • Nandrolone

    Nandrolone

    Product Name:Nandrolone
    Molecular Formula:C18H26O2
    Molecular Weight:274.4
    CAS Registry Number;434-22-0
  • Related Blog
  • Reviews

  • What Is Misoprostol Used For?

    Misoprostol, a derivative of prostaglandin E1, can be used in the treatment of duodenal ulcer, the prevention of anti-inflammatory induced peptic ulcer and the prevention of early pregnancy.It has the function of inhibiting the secretion of gastric acid and preventing the formation of ulcer, thus protecting the gastric mucosa...

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept